Kurt Mathas Speaks on Pharmaceutical Patent Litigation Settlements at Paragraph IV Disputes Conference

Winston & Strawn Partner Kurt Mathas will speak at the 18^th Annual Paragraph IV Disputes Conference, April 19-20, in New York City.

The annual forum—which attracts Hatch-Waxman patent practitioners, leaders from both brand and generic drug companies, and U.S. judges—shapes the law, policy, and proceedings of Paragraph IV litigation.

Kurt will speak on “Reverse-Payment Settlements: Demystifying the Current State of Pharmaceutical Litigation Settlements in the Hatch-Waxman Context” on April 20.

Among other topics, the panel will cover:

• Understanding settlement strategies between brands and generics
• Structuring agreements and identifying antitrust concerns
• Highlighting the state legislation directly addressing “reverse payment” patent settlements
• Reviewing the proper standards of antitrust review and the rising call for a legislative response
• Avoiding costly litigation and associated penalties by effectively complying with the law
• At-Risk Launch considerations

More on Winston’s patent litigation practice.